All research peptides
Research Use OnlyCAS 218949-48-5

Tesamorelin

Tesamorelin is a synthetic analog of endogenous GHRH(1-44) bearing a trans-3-hexenoic acid N-terminal modification that confers enhanced plasma stability. Studied in research on GHRH-receptor agonism and somatotropic (GH/IGF-1) axis signaling.

This product is intended for laboratory research use only.

Tesamorelin
Studied in research for
  • Studied in research as a stabilized GHRH-receptor agonist
  • Investigated in research on the somatotropic (GH/IGF-1) axis
  • Studied in research on lipid- and adipose-tissue metabolism endpoints
Molecular data
Molecular formulaC221H366N72O67S
Molecular weight5135.8 Da
SequenceGHRH(1-44) analog with a trans-3-hexenoyl group on the N-terminal Tyr
AppearanceLyophilized white powder
StorageStore lyophilized powder at −20 °C, protected from light. Reconstituted solution: 2–8 °C, use within the validated window.
Certificate of Analysis
99.6% purity
Lot TES-2606-A · Tested Jul 10, 2026 · Finnrick
Pricing & ordering
Sign in to see live pricing, vial sizes, and stock — free account, no invite code required.

For Research Use Only. All products are intended exclusively for laboratory research use only and are not intended to diagnose, treat, cure, or prevent any disease. The statements on this site have not been evaluated by the U.S. Food and Drug Administration.